Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer
- PMID: 19282103
- DOI: 10.1016/j.eururo.2009.02.023
Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer
Comment on
-
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.Eur Urol. 2009 Jul;56(1):97-103. doi: 10.1016/j.eururo.2009.02.022. Epub 2009 Feb 27. Eur Urol. 2009. PMID: 19282098 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
